Clinical trial
Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis
NCT03180866 is registered in ClinicalTrials.gov with Illumicure Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis
- Lead sponsor
- Illumicure Inc
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 31, 2016
- Completion date
- March 31, 2018
- Enrollment
- 32 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.